- Location
Sagent
"-
Sagent Pharmaceuticals Launches Octreotide Acetate Injection,a Somatostatin Analog
Dec 26, 2013Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
-
US-Based Sagent Pharmaceuticals Has Introduced Propofol Injectable Emulsion USP 1%
Nov 20, 2013US-based Sagent Pharmaceuticals has introduced propofol injectable emulsion USP 1%, in two single-dose, single-patient vial presentations of 20mL and 100mL. The company said that a 50mL single-dose, single-patient vial presentation will ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 14, 2013US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 8, 2013US-based Sagent Pharmaceuticals (SGNT) has introduced an antineoplastic agent 'Carboplatin Injection' in four preservative-free vial presentations. The injection is indicated for the initial treatment of advanced ovarian carcinoma in ...
-
Arsenal Capital Partners announced Today The Acquisition of IFC
Aug 30, 2013Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, announced today the acquisition of International Fiber Corporation ("IFC"), the leading ...
Tags: Fiber, Construction
-
SGNT Has Received The Approval of Zoledronic Acid Injection 4mg/100ml
Aug 9, 2013Sagent Pharma (SGNT) has received the approval of Zoledronic Acid Injection 4mg/100ml, the generic form of the bisphosphonate Zometa, to be packed in a ready-to-use premix IV bag. The new packaging for Zoledronic Acid Injection features ...
Tags: Sagent, Premix Bag, Zoledronic Acid
-
Sagent Has Re-Introduced an Antiarrhythmic Agent Amiodarone HCl Injection
Aug 7, 2013Sagent Pharmaceuticals has re-introduced an antiarrhythmic agent Amiodarone HCl Injection as an improved prefilled plastic syringe compatible with standard I.V. pumps. Featuring Sagent's PreventIV Measures packaging and labeling to help ...
Tags: HCL Injection, Health
-
Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Aug 2, 2013Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
-
Sagent Pharmaceuticals Signed an Agreement to Acquire 50% Interest of Its Joint Venture
May 9, 2013Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m. KSCP will become a wholly-owned ...
Tags: Sagent Pharmaceuticals, Medicine
-
Sagent Pharmaceuticals Opted for Elsevier's Gold Standard's Drug Information Technologies
Mar 18, 2013Specialty pharmaceutical company Sagent Pharmaceuticals has opted for Elsevier's Gold Standard's drug information technologies, ProspectoRx and Clinical Pharmacology to access current and accurate drug data and pricing. ProspectorRx ...
-
Sagent Has Announced The Temporary Importation of 8.4% Sodium Bicarbonate Injection
Jan 11, 2013Sagent Pharmaceuticals has announced the temporary importation of 8.4% Sodium Bicarbonate Injection, USP into the US market from Australia-based Phebra. The temporary arrangement is to address the present critical shortage of non-FDA ...
Tags: Sagent, Sodium Bicarbonate Injection, drug, drug shortage
-
Sagent Pharmaceuticals Has Introduced Flumazenil Injection, USP
Jan 4, 2013Sagent Pharmaceuticals has introduced Flumazenil Injection, USP, available in two latex-free vials featuring the PreventIV Measures packaging and labeling. The benzodiazepine antagonist is indicated for the complete or partial reversal of ...
Tags: Sagent Pharmaceuticals, Flumazenil Injection, USP, PreventIV
-
The Package Insert Contains Detailed Information About The Indications
Dec 13, 2012Pharmaceutical company Sagent has announced the launch of Oxacillin for Injection, USP in three latex-free, preservative-free vial presentations. According to Sagent, the new Oxacillin features its PreventIV Measures packaging and ...
-
Nafcillin Is Unveiled by Sagent Pharmaceuticals for Injection
Dec 4, 2012Sagent Pharmaceuticals has launched Nafcillin for Injection, USP in two vial presentations and one pharmacy bulk package bottle, which are preservative-free and latex-free. Nafcillin had hit nearly $62m sales for 12 months ending ...
Tags: Nafcillin, injection, Sagent Pharmaceuticals, suspected cases
-
Daiichi Sankyo Has Signed an Exclusive Agreement with Coherus BioSciences
Nov 28, 2012Daiichi Sankyo has signed an exclusive agreement with Coherus BioSciences to develop and commercialize biosimilar candidates in certain Asian countries including Japan. The collaboration will focus on the development, manufacturing and ...
Tags: Daiichi Sankyo, Coherus BioSciences, biosimilar candidates
